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Abstract
A scintillation method is presented for determination of the temperature dependence of the
solubility, S(T), of proteins in 50-100 I.tt volumes of solution. S(T) data for lysozyme and horse
serum albumin were obtained for various combinations of pH and precipitant concentrations.
Theresulting kinetics and equilibrium information was used for dynamic control, that is the
separation of nucleation and growth stages in protein crystallization. Individual lysozyme and
horse serum albumin crystals were grown in 15-20 l.tt solution volumes contained in x-ray
capillaries.
\
I. Introduction
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Decades of research on the growth of inorganic crystals from solutions has shown that
high structural quality and uniformity in composition can only be achieved if growth is conducted
slowly and steadily. High growth rates, as well as seemingly small variations in growth-driving
conditions, arc prone to result in defect formation, such as the enhanced formation of dislocations
at growth sector boundaries and the occlusion of mother liquor in growth striations or bands. An
extreme example is the formation of growth bands in ammonium dihydrogen phosphate in
response to growth temperature changes as low as 10 -2 °C [1]. Protein crystals intrinsically grow
much slower than most inorganic crystals at the same supersaturation. This is probably one of the
reasons why it has been widely believed that steadiness and, hence, close control of the growth
conditions, axe not as important for crystal perfection in protein crystallization. Recendy,
however, we have shown that there is alsoa one-to-one correspondence between changes in
growth conditions and defect formation in lysozyme [2]. Changes in the growth temperature of
only a few tenths of a degree resulted in m_scopic solution occlusions. Furthermore, relatively
high growth rates (10 2 A/s) led to an increase in structural defect density, while low growth rates
led to their decrease [2].
These observations corroborate the expectation [3,4] that close control of growth
conditions is as important for the growth of highly perfect protein crystals as it is for inorganic
crystals. Such close control includes means to restrict nucleation events to a few at the beginning
of a crystallization run. Since the pioneering works of Ostwald [5] and Miers and co-workers [6]
it has been known that the formation of a solid nucleus within a mclt or solution requires a
considerably higher undcrcooling or supersaturation than the growth onto a solid in contact with
the same nutrient. A more recent solution growth example for this general behavior is given in
[7]. Hence, in inorganic crystal growth it is common practice to either homogeneously or
heterogeneously seed solutions at supersaturati0ns that arc too low to drive bulk nucleation. Or, if
no single crystalline seeding material is available, the supersaturation is rapidly lowered below the
3nucleationthresholdafter theonset of bulk nucleation. Failure to impose such dynamic control
results in concurrent formation of new nuclei and, often, too rapid growth of the initial nuclei.
This, in turn, leads typically to interference of the crystallites either through the solute field or
through mechanical contact and overgrowth.
Seeding of homoepitaxial growth has been successfully performed by various protein
crystal growers; for examples see [8,9]. For seed transfer from mother solutions, it should be
noted that small differences in the salt concentration of the solutions in which a seed is nucleated
and into which it is transferred for further growth, were found to lead to growth cessation [10].
Heteroepitaxial seeding and growth of proteins on mineral substrates has also been reported [11].
Most recently, some protein single crystals were obtained through graphoepitaxy [ 12].
Supersaturation reduction after initial nucleation, on the other hand, is not typically
provided for in most current protein crystal growth procedures [13,14]. Only the dialysis or
interdiffusion technique possesses some limited internal means toward this end. During dialysis
of the initially separated salt (precipitant) and protein solutions, the concentration gradient and,
thus, the exchange rate across the membrane, decrease with time. Hence, the initial high
supersaturation in the protein solution at the membrane also decays with time, frequently resulting
in fewer crystals than are obtained with other techniques. Toward external supersaturation
control, experiments were made to regulate the humidity content of a gas flow over a hanging
drop in the vapor diffusion technique [15].
Of the many parameters used to drive the nucleation and crystallization of
macromolecules (see, e.g., Table III in [14]) few are technically suitable for supersaturation
control. Of these, temperature control is particularly attractive [16] because a) heat diffuses in
aqueous solutions at least two orders of magnitudes more rapidly than species, b) it can easily be
applied to closed systems, and c) precise temperature control and programming technology is
readily available.
Crystallization of proteins by temperature lowering (with systems of normal solubility) is
cited as early as 1881 [17] and 1892 [18]. In 1949, saturated protein solutions sealed into glass
4capillaries were cooled at rates of 1 °C/hr or less to produce gramicidin S crystals [19,20].
Solutions are often produced at room temperature and then stored in a refrigerator to induce
nucleation, see, e.g., [21,22]. Protein solutions were even briefly brought to -20 °C and then
rewarmed to 5 °C to induce nucleation within hours rather than the days needed at the higher
temperature [23]. Note that the last example includes supersaturation reduction after a nucleation
stage. A few workers have taken advantage of temperature gradients for protein crystallization
[24]. Protein systems with retrograde solubility, typically associated with high salt concentrations
[25-27], have been correspondingly warmed to induce crystallization [28,29]. A particularly
complex system was investigated in [30]: a pure enzyme showed retrograde solubility, but
crystals of a complexed form were obtained by temperature lowering, that is they possessed
normal solubility.
The above examples utilizing temperature changes are presented to illustrate the various
scenarios of protein crystallization. Many more can be found in the literature, see [13,14,31].
Very few investigators, however, have emphasized the need for temperature control and
programming to separate nucleation and growth stages. In our group, a thermostatted solution
growth cell with localized cooling provided by a growth sting was used to grow crystals of both
lysozyme and equine serum albumin [32]. The jacket and sting temperatures were controlled
independently and a radial temperature gradient was established on the sting. The initial
nucleation was restricted to the central region of the sting. Appropriate temperature programming
prevented further nucleation and reduced the number of initial nuclei (crystallites) to inhibit
interference. Other researchers have also been successful in localizing and limiting the number of
nuclei in a similar arrangement [33]. Because these growth cells require solution volumes of the
order of ml and, thus, axe not applicable to less readily available proteins, we have miniaturized
this technique. Its final configuration and application to the growth of proteins from 15-20 _tt
solutions in x-ray diffraction capillaries will be described below.
The optimization of a temperature program for the nucleation and growth of a specific
protein requires data on the temperature dependence of its solubility, S(T), at the salt
5concentrationand pH to be used in the crystallization experiments. To date, systematic studies of
protein solubilities have been limited to tetragonal and orthorhombic lysozyme [34-39], canavalin
[40], and concanavalin A [41]. This scarcity of S(T) data for proteins is partly due to the
relatively large volumes required by the earlier solubility determination techniques [34-37, 40].
Recently, however, micro-techniques were employed that utilize a novel micro-column method
[38,39], the removal of supematants from small drops in which crystals grew [41], or an optical
scintillation technique developed in our group [16]. Hence, solubility data can now be readily
gathered for proteins that are available only in limited quantities. The scintillation technique and
its application to determinations of the S(T) of tetragonal lysozyme and horse serum albumin,
involving carefully prepared solutions (Section 2) is described in Section 3. The application of
these S(T) data to temperature-controlled growth in x-ray capillaries is presented in Section 4.
2. Solutionpreparation
2.1 Hen egg-white tysozyme
Lysozyme chloride from chicken egg-white (Grade VI, L2879, 90% protein, 10% buffer
salts) was purchased from Sigma Chemical Company. The as-received protein was dissolved at
room temperature in deionized and Millipore-filtered (0.22 l.tm) ultra pure biological type-1 water
(diH20). The solution was filtered with a sterile Nalgene filter with an average pore size of 0.2
I.tm.
Because as-received protein can vary in composition between batches, we performed
analytical SDS-PAGE (sodium dodecyl sulfate-polyacrylamide gel electrophoresis) to charac-
terize the purity of lysozyrne. In all cases, using either Coomassie Blue or silver staining, only "
one band was obtained at molecular weight ---14,500.
In order to establish a well-defined salt concentration in the growth solutions, all salt
present in the as-received lysozyme was removed. For this, the filtrate was placed in dialysis
tubing (molecular weight cutoff =8,000) and dialyzed against deionized water for about 30 hours
with at least two changes of diH20. In previous experiments with NaCI solutions of known
6concentrations, using a Na + specific electrode, we found that in our apparatus two complete water
changes in 25 hours were sufficient for quantitative salt removal.
The protein was then dialyzed for a total of 60 hours against 0.05M acetate buffer at pH =
4.5, with 0.01 (w/v)% NaN3 added to inhibit microbial growth. The buffer solution in the
reservoirwas pcriodicaUyreplaced. Afterthe dialysis,the lysozym¢ solutionwas filteredthrough
a 0.2 _ Nalgen¢ filter,and then conccntratedto approximately 110 mg/ml of solutionusing an
Amicon ultraffltrationapparatus. The pH of thisprotein stock solution was checked with an
(3don SA 520 pH meter. Lysozyme stock solutionswere stored at 4 °C. In addition,stock
solutionsof 10 (w/v)% NaCI in0.05 M acetatebufferof pH = 4.5 with 0.01 (w/v)% NaN3 were
storedat4 °C.
Finalsolutionsamples wcrc prepared atroom temperature by adding volumes of thestock
solutionsof proteinand salt,and buffcrto obtainthe desiredconcentrations.These volumes wclrc
delivered with Eppendorf pipettes,which have precisionand accuracy for the viscous protein
solutionsof ± 0.4% and ± 1.2%, respectively.These were determined through weighing a large
number of deliveredvolumes. The saltsolutionwas added lastand the sample was immediately
vortcxcd to ensure thorough mixing of the components. The solutionwas then centrifugedat
9,000 rpm in a Savant microccnu'ifuge to remove any particulatematter. The supcrnatantwas
thenpH-corrected to pH = 4.5 using eitherglacialaceticacidor sodium acetate,analyzed forfinal
proteinconcentration (see below) and u'ansferredthrough syringes with 0.2 _m filtersintothe
scintillationccUs or capillarygrowth tubes.
The protein concentrations in the stock and finalsolutions were determined by UV
absorbance measurements at 280 nm with a Beckman DU-68 spectrophotometer. The
conccntration of lysozyme was calculated using Beer's Law, A = otl C, where A is the
absorbance (thenatural logarithm of the ratioof impinging to transmittedintensity),ctisthe
absorptioncoefficient,I is the pathlcngth [cm], and C is the concentration [mg/mt]. We used
a 280nm = 2.64 [ml/(mg cm)] for the absorption coefficient[42], and carried out multiple
absorbance readings toincreaseconfidence in thesample concentrations.
72.2 Horse serum albumin
Horse serum albumin (also referred to as equine serum abumin, ESA) was obtained in
powder form from Sigma Chemical Company (A5280, Cohn's Fraction V, essentially fatty acid
free, 99 % albumin). The precipitant and pH conditions chosen (40-50 (w/v)% ammonium
sulfate, pH = 5.5) were found advantageous for single crystal growth by other workers [43]. Note
that these precipitant concentrations are much higher than in the lysozyme system.
The preparation of stock solutions containing 150-200 rag/mr ESA, with 0.05 M acetate
buffer at pH = 5.5 and 0.01 (w/v)% NAN3, followed essentially the procedure described above for
lysozyme, without the salt removal step. The purity of the as-received protein was again checked
by SDS-PAGE, and by isoelectric focusing. The three most probable contaminating proteins are
the o_-, 13---,and y- globulins with isoelectric points at pH - 4.9, 6.3, and 6 to 7, respectively [44].
The published isoelectric point for equine serum albumin is pH = 4.9 [44]. Some multiple bands
were seen between pH - 4.5 to 5.3, possibly indicating the presence of 0t-globulin. However, the
molecular weight determinations clearly showed single bands around ESA's reported molecular
weight of 67,500 [45], but no bands around the molecular weight of cx-globulin of approximately
147,000 [46]. Thus, we concluded that the ESA was essentially free from contaminating proteins,
and that the multiple banding was due to the well-known microheterogeneity of the albumin itself
[47].
ESA stock solutions of 0.05 M acetate buffer at pH = 5.5 with 0.01 (w/v)% sodium azide
added to inhibit microbial growth were stored at 4 °C for no more than two weeks. Longer
storage can lead to significant increases of the microheterogeneity of ESA [48]. Saturated
ammonium sulfate solutions (61.2 g ammonium sulfate, 100 g pH = 5.5 buffer) were stored at
room temperature to prevent crystallization.
To our knowledge, absorption data
determinations, had not been reported before.
for ESA, needed for optical concentration
Hence, we determined the UV spectrum and
calibrated the absorbance as a function of concentration. Fig. 1 shows, for a solution containing
1.79 mg/mt ESA, that the absorption has a maximum at 276 nm, with an absorbance of 0.725.
Fig. 2 presentstheabsorbance at this wavelength obtained for solutions of various concentrations.
The straight line was derived from these data with a correlation coefficient of 1.00, thus
confirming Beer's law behavior. The slope of the line, i.e. an absorption coefficient of a 276nm =
0.404, was used for our concentration determinations.
3. Solubility measurements
3.1 Apparatus and procedures
Fig. 3 presents an exploded view of the scintillation arrangement used in our solubility
studies. Between 50-100 I.tt of solution _:eontained in a jacketed silica micro-cell (Wilmad
Glass Co., model WG-65-Q-1) which is connected to a programmable constant temperature (+
0.1 °C) recirculator bath (Polyscience, model 90). A laser beam from a serf-contained laser diode
assembly (MWK Industries, model CN 12, 5 mW) is directed through the solution. Light
scattered normal to the beam is detected by a photodiode (United Detector Technology, model
UDT 455) through a solid glass ground joint that seals the port of the cell, thus preventing
evaporation of solvent. The temperature of the solution is monitored with a glass-bead thermistor
(not shown) that is inserted through a groove in the ground joint. A beam splitter (Edmund
Scientific, stock number A 32,601) between laser and cell diverts some of the laser's output to a
second photodiode, the signal of which is used to compensate for intensity fluctuations in the
impinging light. Backscatter of light that passes through the cell is minimized by a beam stop or
light trap consisting of black fabric in a cavity formed by a rotating magnet. This magnet
(Magnetic Fabricators, model AM-306-RH) drives a small nickel wire (0.6 mm diameter and 7
mm long) used as a stirring bar insidethe lower part of the solution which is not illuminated by the
laser beam. The cell and the laser/beam-splitter housing are held in place by five rectangular
Plexiglas parts, see fig. 3, which require only three bolts (not shown) for their assembly. The
whole assembly, together with a stirring motor (Hurst Mfg., model T-ET P/N 2609-001, 300
rpm), is housed in a light-tight metal can. The output of the two photodiodes and the thermistor
are fed to a Macintosh computer via a MacADIOS Model 411 interface for data acquisition and
9display. In turn, the temperature of the re,circulator bath is programmed from the computer
through this interface according to the changes in scintillation signal with time, see below.
A solubility point is determined as follows. After filling the cell with a solution of
predetermined composition, the bath temperature is lowered (or raised in retrograde solubility
systems) to a value at which nucleation and crystallite growth are expected to set in after some
reasonable length of time, causing a distinct increase in the photodiode signal. Then the
temperature is raised. Fig. 4 displays the temperature changes, imposed manually in this fast
transient, and the corresponding photodiode output (scintillation signal) in a run with a solution
containing about 50 mg/mt of lysozyme and 2.5(w/v)% NaC1. The low background in the diode
signal is the result of reflections from some sub-micron particulates and from the cell surfaces.
One sees that, in spite of about 20-fold supe_turation of this solution at the low temperature of 7
°C (see fig. 6), the formation of crystallites requires about one hour. Note that at 10 °C this
requires about 6 hours, well illustrating the exponential dependence of nucleation rates on
supersaturation. Interestingly, the scintillation signal increases for some time even after the
temperature is reset to a higher value (20 °C in fig. 4). This reflects the coarsening of the
crystallites during this period.
After the manually controlled initial nucleation stage, the temperature is automatically
increased in increments of 0.5 or 1 °C by the computer. Fig. 5 shows a temperature trace with
corresponding scintillation signal levels for a lower concentration solution; for details see figure
caption. In this run the scintillation light level was so high that the photodiode became saturated.
When the solubility temperature is approached, the signal begins to drop due to sufficient
dissolution of some of the crystallites. At a given temperature T the signal tends to level-off
corresponding to the concentration of remaining crystallites that are in equilibrium with the
solution at T. In order to save measurement time, however, the temperature is automatically
changed by another increment as soon as the slope of the scintillation signal curve falls below a
prescribed value. Hence the scalloped shape of the curve. When all crystaUites have dissolved,
the signal returns to the baseline. At the endpoint a small amount of solution is extracted from the
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cell through a microsyringe with filter (Millipore Acrodisc, 0.2 _m pore size) for optical
concentration determination after appropriate dilution. Of course, the endpoint can be shifted to
higher values by the formation of significant amounts of denatured proteins. _s, however, can
be recognized by the absence of a scallop on further temperature lowering.
The stirring of the cell solution serves several purposes. Foremost, it keeps the crystallites
in suspension, which otherwise would sediment and not contribute to the scintillation signal.
Stirring also expedites the nucleation process and the equilibration between crystallites and
solution. This and the semi-antomation of the procedure are essential in view of the slow kinetics
involved.
3.2 Lysozyme solubilities
We have determined the temperature dependence of lysozyme solutions at 2.1 (w/v)%, 2.5
(w/v)%, and 3.0 (w/v)% NaCI and pH 4.5. The results, presented in fig. 6, reflect normal
solubilitybehavior,as wellas thewidely-occurringtrendofdecreasingsolubilitywithincreasing
saltconcentration, salting-outbehavior [49]. The solidlinescorrespond to thirdorder
polynomialfits,with thecoefficientsand averagedeviationslistedin tableI.The dashed lines
representheresultsobtainedby Pusey etal.at2.0(w/v)% and 3.0(w/v)% NaCI withtheequally
rapidmicrocolumn technique[39].Intherangewere theconditionsoverlap,thedataagreewell.
Furthermore,the2.5 (w/v)% datawere nicelyconfirmedinkinetics tudiesin which lysozyme
crystalsunder conditions lightlytotheleftor right,respectively,of themiddle curve infig.6
clearlygrew oretched[2].
Note,however, thatour solubilitiesareconsiderablylower than thoseobtainedwith the
batch method [34]. Batch methods, due to their essentially diffusion-limited equilibration of large
volumes, require stable conditions over periods as long as ten months. Over such long periods it
is difficult to keep the temperatures constant (power failures!), and to prevent microbial
contamination and leakage of the solutions. Another problem with the lysozyme batch data appear
to have arisen from the coexistence of tetragonal and orthorhombic crystals forms. Orthorhombic
crystals, more stable than the tetragonal at the higher temperatures, possess lower solubilities.
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Thus, subject to the equilibration kinetics of the two forms, the superposition of the different
solubility curves can lead to the previously reported solubility maximum [34]; for more details see
[32]. In the scintillation investigations, only the tetragonal form was present because
orthorhombic crystals require longer periods to form.
3.3 Horse serum albumin solubilities
Solubilities for equine serum albumin were obtained at 45 wt%, 47 wt%, and 51 wt%
ammonium sulfate and pH = 5.5. In comparison with the lysozyme studies, the ESA solubility
measurements required significantly longer experiment times due to slower dissolution kinetics.
The results are displayed in fig. 7 and reflect the retrograde solubility behavior qualitatively
observed by McMeekin in 1939 [45]. The solid lines correspond to fifth-order ploynomial fits,
with the coefficients and average deviations listed in table 2. Unexpectedly, the data show first a
salting-out and then salting-in behavior with increasing ammonium sulfate concentration. This
and the relatively large scatter in data prompt us to view these results with some reservation.
3.4 Canavalin solubilities
Canavalin studies are discussed here to illustrate some limitations of the scintillation
technique and, correspondingly, of the temperature control of crystallization. Canavalin was
isolated from jack bean meal (Sigma J-0124, Lot 37F-3720) using the isolation procedure of
Smith et al. [50]. Canavalin was also obtained from Prof. A. McPherson, University of California
at Riverside. Details of the preparation of the 1.3 (w/v)% NaC1 solutions used are given in [32].
Canavalin solubility was initially believed to have a strong temperature dependence. However,
the nucleation response was so slow that, even with seeding, a typical canavalin experiment
required 3-5 days to complete, in addition, the scintillation signals usually remained below 15%
of the response obtained with lysozyrne and ESA.
In batch crystallizations we found that, as had been observed earlier [50,51], in the
solutions where crystals formed, the pH had increased significantly. Even though buffered at an
initial pH of 5.5, the pH of our solutions was found to increase up to as 6.6. Further experiments
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suggested,in agreementwith findings of others [52], that the solubility of canavalin depends
more on pH than on temperature. Thus we concluded that, under the solution conditions used,
canavalin is a poor candidate for temperature controlled crystallization [32].
4. Crystal growth in x-ray capillaries
The major advantages of protein crystallization in x-ray capillaries are that only small
solution volumes are required and potentially damaging crystal handling between growth and
diffraction studies can be avoided; for rnore details see [53]. An additional advantage of thin-
walled capillaries is that heat flow in the wall in axial directions is minimal. Hence, temperature
changes to induce nucleation by external means can be highly localized. In the following, we
describe our experimental setup and procedures used for the growth of single crystals of lysozyme
and ESA.
4.1 Apparatus and loading
Fig. 8 presents a cross-sectional view of our growth apparatus. An x-ray capillary
(Charles Supper Co, Glaskapillaren) containing 15-20 gl of protein solutio, rests on one side on a
small tapered copper block which is in good thermal contact with a miniature thermoelectric
(Peltier) heat pump (Marlow Industries, model MI 1021T). The temperature of the copper block
is monitored with a bead thermistor (Marlow, model till) which also provides the signal for a
temperature controller (Marlow, model SE 5010) that powers the heat pump. The lower side of
the Peltier unit is in thermal contact with a heat conductor that rests on the inner wall of double-
walled thermostatted glass jacket. Depending on the mode of operation of the heat pump, the heat
conductor and glass jacket act as heat sink or source. With this arrangement the temperature of
the copper block and, thus, of the spot of the capillary wall that is in contact with the block, can be
programmed between 8 °C and 50 °C with a resolution of + 0.1 °C. Similarly, the jacket, which is
thermostatted by a programmable constant temperature recirculator bath (Neslab, model RTE
100) maintains the temperature of the remainder of the capillary to within + 0.1 °C at some (other)
predetermined value. Tight sealing of the jacket with a rubber stopper, which serves also as
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feedthrough for the various lead wires, is important to prevent condensation of moisture on the
heat pump at sub-ambient operation. The air inside the jacket is dried by some silica gel beads
(not shown) to ensure safe heat pump operation and good viewing of nucleation and growth
through a Wild long focal length microscope.
Capillary tubes were cleaned with an enzymatic action detergent and concentrated sulfuric
acid, then thoroughly rinsed with filtered deionized water, and dried in a vacuum oven at -120 *C
for several hours. After sealing one side with a quick-setting epoxy, the capillary was charged
with the solution through a microsyringe and sealed on the other side.
4.2 Crystal growth
Fig. 9 shows a lysozyme crystal (0.8 mm x 0.9 ram) grown in the above arrangement and
photographed through the x-ray capillary, the edges of which correspond to the upper and lower
edges of the photograph. The initial solution composition was 50 rag/mr, 3 (w/v)% NaC1 and pH
= 4.5; see the right curve in fig. 6. Nucleation of one crystal was observed 45 rain after cooling
the copper block to 7 °C, while the jacket was set to 32 °C. Immediately after nucleation was
detected, the copper block temperature was increased to 19 °C, where the crystal shown in fig. 9
grew within 16 hrs.
The growth of only one crystal in the above run was somewhat fortuitous. However, we
have always succeeded in limiting the number of crystals to 1-3 in all other runs by raising the
"cold spot" temperature to the growth temperature even before the appearance of a macroscopic
crystallite, thus reducing the chance for the successive formation of nuclei. Guidance for an
advantageous choice of the nucleation induction time can be obtained from the initial transient"
time in the scintillation experiments; see fig. 4. One must take into account, however, that in
these experiments multiple nucleation is desirable. Hence, one will chose somewhat lower
supersamrations for the growth runs.
For the growth of ESA crystals, according to their retrograde solublity (fig. 7), the copper
block temperature must be increased. Fig. 10 depicts an ESA crystal (0.94 mm x 0.06 ram) that
was grown from a solution of initial 40 rag/mr protein concentration at pH = 5.5 and 45 wt% of
ammoniumsulfate. Nucleation occurred after 2 hrs at 26 °C, and growth was conducted at 20 °C
for about 200 hrs. The jacket temperature was kept at 19 °C throughout.
5. Conclusions
The scintillation technique presented here is well suited for determination of the
temperature dependence of the solubility of proteins in 50-100 _tt volumes of solution. The
kinetics and equilibrium information gained from such determinations can be readily used for the
dynamic control, i.e. the separation of nucleation and growth stages, in protein crystallization. X-
ray capillaries can be advantageously used _ temperature-controlled solution growth of individual
protein crystals.
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Figure Captions
Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.
Fig. 7.
Fig. 8.
UV absorption spectrum of solution of 1.79 mg/ml horse serum albumin solution
with 0.05 M acetate buffer, pH -- 5.5.
Absorbance vs. concentration for horse serum albumin solutions with 0.05 M acetate
buffer, pH - 5.5.
Scintillation arrangement for solubility studies, exploded view. See text for
explanation.
Temperature trace and corresponding photodiode signal during initial, manually
imposed nucleation and crystallite growth in scintillation experiment with 50 mg/mt
lysozyme solution at 2.5 (w/v)% NaC1 and pH = 4.5.
Temperature trace and corresponding photodiode signal during automatically
controlled redissolution of crystallites in scintillation experiment with 11.1 me/rot
lysozyme solution at 2.1 (w/v)% NaC1 and pH = 4.5.
Temperature dependence of solubility of lysozyme in solutions with pH = 4.5 and
various salt concentrations. Symbols: experimental data; solid curves: polynomial
fits, see table 1; dashed curves: results obtained by Pusey et al. [39] at 2.0 (w/v)%
NaC1 (upper curve) and 3.0 (w/v)% NaC1 (lower curve).
Temperature dependence of solubility of horse serum albumin in solutions with pH =
5.5 and various ammonium sulfate concentrations. Symbols: experimental data; solid
curves: polynomial fits, see table 2.
Experimental arrangement for the temperature-controlled growth of protein crystals in
x-ray capillaries; cross-sectional view.
Lysozyme single crystal grown by dynamic temperature control in x-ray capillary.
Horse serum albumin single crystal grown by dynamic temperature control in x-ray
capillary.
Table1:
Thirdorderpolynomialfits to Lysozymesolubilitydatain mg/mt = A
with T [°C].
+ BT + CT 2 + DT 3
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NaCI (w/v)% A B C x 10 D x 103 Avg. Dev. %
2.1 -58.8 9.18 -4.37 8.72 2.5
2.5 -55.1 9.31 -4.95 9.59 0.6
3.0 -215.4 27.7 -11.8 17.5 0.8
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Table2:
Fifth orderpolynomialfits to ESAsolubilitydatain mg/mt -- A
with T [°C].
+ BT + CT 2 + DT 3 + ET 4 +b'T 5
Am. Sulf. wt% A B C D x 10 E x 103 F x 105 Avg. Dev. %
45 57.9 7.82 -2.07 1.39 -3.75 3.36 0.7
47 92.1 -23.5 2.76 -1.63 4.66 -5.10 0.7
51 51.8 6.98 -2.46 2.08 -7.15 8.74 2.8
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